Tizanidine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies
Condition:   Malignant Melanoma, NeoplasmsInterventions:   Drug: tizanidine;   Drug: vemurafenibSponsor:   Hoffmann-La RocheCompleted - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2013 Category: Research Source Type: clinical trials

A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies
Condition:   Malignant Melanoma, NeoplasmsInterventions:   Drug: tizanidine;   Drug: vemurafenibSponsor:   Hoffmann-La RocheCompleted - verified June 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2013 Category: Research Source Type: clinical trials

A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies
Condition:   Malignant Melanoma, NeoplasmsInterventions:   Drug: tizanidine;   Drug: vemurafenibSponsor:   Hoffmann-La RocheCompleted - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2013 Category: Research Source Type: clinical trials

A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies
Condition:   Malignant Melanoma, NeoplasmsInterventions:   Drug: tizanidine;   Drug: vemurafenibSponsor:   Hoffmann-La RocheRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2013 Category: Research Source Type: clinical trials

A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies
Condition:   Malignant Melanoma, NeoplasmsInterventions:   Drug: tizanidine;   Drug: vemurafenibSponsor:   Hoffmann-La RocheRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2013 Category: Research Source Type: clinical trials

A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies
Condition:   Malignant Melanoma, NeoplasmsInterventions:   Drug: tizanidine;   Drug: vemurafenibSponsor:   Hoffmann-La RocheRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2013 Category: Research Source Type: clinical trials

A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies
Condition:   Malignant Melanoma, NeoplasmsInterventions:   Drug: tizanidine;   Drug: vemurafenibSponsor:   Hoffmann-La RocheRecruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2013 Category: Research Source Type: clinical trials

A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies
Condition:   Malignant Melanoma, NeoplasmsInterventions:   Drug: tizanidine;   Drug: vemurafenibSponsor:   Hoffmann-La RocheCompleted - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2013 Category: Research Source Type: clinical trials